| ²é¿´: 532 | »Ø¸´: 2 | |||
hongannieгæ (СÓÐÃûÆø)
|
[ÇóÖú]
Çó·Òë½âÊÍ ÒÑÓÐ2È˲ÎÓë
|
|
The resulting Cmax exposure to LBQ657 (2,686 ng/mL total; 537 ng/mL unbound; assuming 80% bound and 20% unbound; as extrapolated from a single dose of 24 mg/kg dose in [CRA-11-014 Main Report]) was approximately 11-fold higher than the Cmax observed following dosing of LCZ696 200 mg BID to patients with heart failure. |
» ²ÂÄãϲ»¶
¼±Ðèµ÷¼Á
ÒѾÓÐ8È˻ظ´
É격/¿¼²©
ÒѾÓÐ4È˻ظ´
»¯¹¤Ñ§Ë¶294·Ö£¬Çóµ¼Ê¦ÊÕÁô
ÒѾÓÐ37È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
260Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸»ªÖÐũҵ071010£¬320Çóµ÷¼Á
ÒѾÓÐ19È˻ظ´
304Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
Ç󲩵¼£üÉúÎïÖÊ»ù¶à¿×̼/³¬¼¶µçÈÝ·½Ïò£¬ÒÑÓÐÏà¹Ø³É¹û£¬Ñ°ÄÜÔ´²ÄÁÏ/̼²ÄÁÏ·½ÏòÀÏʦ
ÒѾÓÐ3È˻ظ´
¶þ±½¼×ͪËáÀàÑÜÉúÎï
ÒѾÓÐ6È˻ظ´
½ÓÊÜÈκε÷¼Á
ÒѾÓÐ4È˻ظ´
baoshanqiu
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 103 (¸ßÖÐÉú)
- ½ð±Ò: 15293.5
- ºì»¨: 41
- Ìû×Ó: 1611
- ÔÚÏß: 431.6Сʱ
- ³æºÅ: 3856202
- ×¢²á: 2015-05-08
- ÐÔ±ð: GG
- רҵ: 賦µÀÃâÒßÏà¹Ø¼²²¡
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
hongannie: ½ð±Ò+5 2015-09-02 15:28:51
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
hongannie: ½ð±Ò+5 2015-09-02 15:28:51
| µÃµ½µÄÕë¶Ô LBQ657£¨×ܹ²2,686 ng/mL £¬537 ng/mLδ½áºÏ£»¼ÙÉè80%½áºÏ£¬20% δ½áºÏ£»ÓÉ[CRA-11-014 Ö÷±¨¸æ] ÖÐ24 mg/kgµ¥´Î¸øÒ©ÍâÍÆ¶øµÃ£©µÄCmax¼¸ºõÊÇ´Ó LCZ696 200 mg BID ¸øÒ©ÐÄË¥²¡È˹۲쵽µÄCmaxµÄ11±¶¡£ |
2Â¥2015-08-22 03:44:44
krispanlove
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 26 (СѧÉú)
- ½ð±Ò: 719.4
- ºì»¨: 21
- Ìû×Ó: 254
- ÔÚÏß: 29.1Сʱ
- ³æºÅ: 3898944
- ×¢²á: 2015-05-30
- ÐÔ±ð: MM
- רҵ: »·¾³¹¤³Ì
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
| µÃµ½µÄÕë¶Ô LBQ657£¨×ܹ²2,686 ng/mL £¬537 ng/mLδ½áºÏ£»¼ÙÉè80%½áºÏ£¬20% δ½áºÏ£»ÓÉ[CRA-11-014 Ö÷±¨¸æ] ÖÐ24 mg/kgµ¥´Î¸øÒ©ÍâÍÆ¶øµÃ£©µÄCmax¼¸ºõÊÇ´Ó LCZ696 200 mg BID ¸øÒ©ÐÄË¥²¡È˹۲쵽µÄCmaxµÄ11±¶¡£ |

3Â¥2015-08-24 17:34:24













»Ø¸´´ËÂ¥